Dual Role of Interleukin-23 in Epicutaneously-Sensitized Asthma in Mice

  • Masaki Katsunori
    Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
  • Suzuki Yusuke
    Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine MSD Endowed Program for Allergy Research, Keio University School of Medicine
  • Kagawa Shizuko
    Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine MSD Endowed Program for Allergy Research, Keio University School of Medicine
  • Kodama Motohiro
    Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
  • Kabata Hiroki
    Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
  • Miyata Jun
    Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
  • Tanaka Kyuto
    Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
  • Fukunaga Koichi
    Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
  • Sayama Koichi
    Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
  • Oguma Tsuyoshi
    Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine
  • Kimura Tokuhiro
    Department of Pathology, Keio University School of Medicine Present address: Department of Pathology, Yamaguchi University Graduate School of Medicine
  • Amagai Masayuki
    MSD Endowed Program for Allergy Research, Keio University School of Medicine Department of Dermatology, Keio University School of Medicine
  • Betsuyaku Tomoko
    Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
  • Asano Koichiro
    Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine MSD Endowed Program for Allergy Research, Keio University School of Medicine Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine

Search this article

Description

Background: Interleukin (IL)-23/Th17 axis plays an important role in the pathophysiology of asthma and eczema, however, there are some conflicting data about the effects of this system on allergic airway inflammation. In the present study, we aim to dissect the spatiotemporal differences in the roles of IL-23 in an epicutaneously-sensitized asthma model of mice.<br> Methods: C57BL/6 mice were sensitized to ovalbumin (OVA) by patch application on the skin, followed by airway exposure to aerosolized OVA. During sensitization and/or challenge phase, either a specific neutralizing antibody (Ab) against IL-23 or control IgG was injected intraperitoneally. On days 1 and 8 after the final OVA exposure, airway inflammation and responsiveness to methacholine, immunoglobulin levels in serum, and cytokine release from splenocytes were evaluated. Skin Il23a mRNA levels were evaluated with quantitative RT-PCR.<br> Results: Patch application time-dependently increased the expression of Il23a mRNA expression in the skin. Treatment with the anti-IL-23 Ab during sensitization phase alone significantly reduced the number of eosinophils in bronchoalveolar lavage fluids and peribronchial spaces after allergen challenge compared with treatment with control IgG. Anti-IL-23 Ab also reduced serum levels of OVA-specific IgG1. In contrast, treatment with the anti-IL-23 Ab during the challenge phase alone rather exacerbated airway hyperresponsiveness to methacholine with little effects on airway eosinophilia or serum IgG1 levels.<br> Conclusions: IL-23 expressed in the skin during the sensitization phase plays an essential role in the development of allergic phenotypes, whereas IL-23 in the airways during the challenge phase suppresses airway hyperresponsiveness.<br>

Journal

Citations (2)*help

See more

References(31)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top